Backed by 10+ Clinical Studies

Safety and effectiveness of qingdai (indigo naturalis) in children with mild-to-moderate ulcerative colitis: a short-term 6-week open-label trial

Inflammatory Bowel Diseases, 2025

Curcumin-qingdai combination as treatment for crohn’s disease: a case report

Case Reports in Gastroenterology, Volume 19

Vedolizumab plus curcumin-qingdai for patients with ulcerative colitis

Inflammatory Bowel Diseases, Volume 31

Curcumin-qingdai combination for patients with active crohn’s disease

Journal of Crohn's and Colitis (JCC), Volume 19, Volume 19 & Presented at DDW 2025, ECCO 2025

Real-world experience of curcumin+qing dai reduces biochemical and intestinal ultrasound disease markers in patients with inflammatory bowel disease

Journal of Crohn's and Colitis (JCC), Volume 19

The efficacy of curcumin/qing dai combination in children with active ulcerative colitis: a multicenter retrospective cohort study

Frontiers Pediatrics, Volume 12

Change in bowel urgency in active ulcerative colitis patients treated with curcumin-qingdai (curqd): a post hoc analysis of a randomized placebo-controlled trial

Journal of Crohn's and Colitis (JCC), Volume 19

Curcumin-qingdai combination for patients with active ulcerative colitis: a randomized, double-blinded, placebo-controlled trial

Clinical Gastroenterology and Hepatology (CGH), Volume 22

Cgh editorial by harvard professor ashwin ananthakrishnan

Clinical Gastroenterology and Hepatology (CGH), Volume 22

Clinical, biochemical, and intestinal ultrasonography response to curcumin-qingdai (curqd) combination in pediatric patients with inflammatory bowel disease

Inflammatory Bowel Diseases, Volume 30

Real-world experience with Curcumin–QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study

Alimentary Pharmacology & Therapeutics (APT), Volume 58